Thermo Fisher Scientific | TMO - 当期純利益

株価
496.11
毎日の変更
-4.35 -0.87%
毎月
0.08%
毎年
13.23%
Q2 予測
482.57




当期純利益 変化する 日付
Abbott USD 1.78B 132M 2025-12
Agilent USD 305M 129M 2025-12
Becton, Dickinson and Co. USD 382M 111M 2025-12
Bio Techne USD 38.01M 176K 2025-12
Bio-Rad Laboratories USD -341.9M 659.7M 2025-09
Boston Scientific USD 672M 83M 2025-12
Bruker USD 26M 88.4M 2025-12
Charles River Laboratories USD -276.56M 330.98M 2025-12
Danaher USD 1.2B 289M 2025-12
Dentsply International USD -146M 281M 2025-12
Edwards Lifesciences USD 91.2M 199.9M 2025-12
General Electric Aerospace USD 2.54B 384M 2025-12
Henry Schein USD 101M 0 2025-12
Hologic USD 179.1M 8.2M 2025-12
Illumina USD 334M 184M 2025-12
Intuitive Surgical USD 794.8M 90.4M 2025-12
IQVIA Holdings USD 514M 183M 2025-12
Laboratory Of America USD 164.7M 96.4M 2025-12
Medtronic USD 1.14B 231M 2025-12
Mettler Toledo International USD 285.76M 68.27M 2025-12
Myriad Genetics USD -7.9M 19.5M 2025-12
Olympus JPY 14.17B 6.03B 2025-12
OraSure Technologies USD -19.29M 5.57M 2025-12
Quest Diagnostics USD 245M 0 2025-12
Repligen USD 13.29M 1.62M 2025-12
Revvity USD 98.36M 51.71M 2025-12
Stryker USD 849M 10M 2025-12
Thermo Fisher Scientific USD 1.96B 348M 2025-12
Veracyte USD 41.15M 22.01M 2025-12
Waters USD 225.21M 76.29M 2025-12
Zimmer Biomet Holdings USD 139.3M 91.6M 2025-12